Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Chondrodysplasia - disorder of sex development is an extremely rare disorder of sex development, reported in only two siblings (one terminated in pregnancy) to date, characterized by the clinical features of 46,XY complete gonadal dysgenesis (normal external female genitalia, lack of pubertal development, primary amenorrhea, and hypergonadotrophic hypogonadism) in association with severe dwarfism with generalized chondrodysplasia (bell-shaped thorax, micromelia, brachydactyly). Other reported features in the live sibling included eye anomalies (hypoplastic irides, myopia, coloboma of optic disks), dysmorphic features (deep-set eyes, upslanting palpebral fissures, puffy eyelids, large ears and mouth, mild prognathism), muscular hypoplasia, mild intellectual deficiency and severe microcephaly with cerebellar vermis hypoplasia. An autosomal recessive inheritance has been suggested.
Features include always present findings: Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Upslanted palpebral fissure, Distal clavicular thinning, and Bell-shaped thorax and others; and very common findings: Severe short stature, Microcephaly, Micromelia, and Short metacarpal and others. 37 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 |
HHAT encodes hedgehog acyltransferase (493 aa). Palmitoyl acyltransferase that catalyzes N-terminal palmitoylation of SHH; which is required for SHH signaling. It also catalyzes N-terminal palmitoylation of DHH. Highest expression in Thyroid (4.9 TPM) and Adrenal Gland (4.8 TPM).
Chondrodysplasia-pseudohermaphroditism syndrome is associated with mutations in the HHAT gene on chromosome 1.
The HHAT protein participates in HHAT palmitoylates Hh N-terminal fragment, HHAT G287V doesn't palmitoylate Hh-Np, and HHAT G278V doesn't palmitoylate Hh-Np pathways.
HHAT is classified as a druggable target (Druggable Genome and Enzyme categories) with score 0.0.
Genetic testing for HHAT is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for chondrodysplasia-pseudohermaphroditism syndrome has been reported in the published literature.
Phenotype severity distribution: 5 always present features, 14 very common features, 18 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for chondrodysplasia-pseudohermaphroditism syndrome.
301 publications have been identified in PubMed for chondrodysplasia-pseudohermaphroditism syndrome. Kisho has analyzed 141 by research type. Research spans Review / Meta-Analysis (63%), Basic Science / Preclinical (13%), and Epidemiology / Natural History (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 89 | 63% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 8:44 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Bones and joints | 3 | Trapezoidal vertebral body, Abnormal pelvic girdle bone morphology, Broad long bones |
Growth and development | 2 | Severe short stature, Intrauterine growth retardation |
Muscles | 2 | Low muscle tone (hypotonia), Muscle spasm |
Eyes | 2 | Optic disc coloboma, Strabismus |
Lab test results | 1 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration) |
Head and neck | 1 | Microcephaly |
Skin | 1 | Nail dysplasia |
Arms and legs | 1 | Short phalanx of finger |
Laboratory research |
19 |
13% |
Disease patterns and progression | 17 | 12% |
Patient case studies | 7 | 5% |
Other research | 4 | 3% |
Testing and diagnosis research | 4 | 3% |
Clinical study results | 1 | 1% |
Ferri C (2026). [PMID: 41798958](https://pubmed.ncbi.nlm.nih.gov/41798958/). *Front Immunol*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Epidemiology / Natural History]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Biglari S (2025). [PMID: 40101970](https://pubmed.ncbi.nlm.nih.gov/40101970/). *J Med Genet*. [Basic Science / Preclinical]
Koriath CAM (2025). [PMID: 39443079](https://pubmed.ncbi.nlm.nih.gov/39443079/). *J Neurol Neurosurg Psychiatry*. [Review / Meta-Analysis]
Sahoo SS (2025). [PMID: 39475954](https://pubmed.ncbi.nlm.nih.gov/39475954/). *Blood*. [Review / Meta-Analysis]
Pignataro G (2025). [PMID: 41010942](https://pubmed.ncbi.nlm.nih.gov/41010942/). *Medicina (Kaunas)*. [Review / Meta-Analysis]
Yildizdal S (2025). [PMID: 39848875](https://pubmed.ncbi.nlm.nih.gov/39848875/). *J Craniomaxillofac Surg*. [Other]